Avoro Capital Advisors’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Hold |
0
| – | – | – | 32 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 40 |
|
|
2017
Q3 | – | Sell |
-219,500
| Closed | -$10.1M | – | 42 |
|
|
2017
Q2 | $10.1M | Buy |
+219,500
| New | +$10.1M | 1.27% | 23 |
|
|
2017
Q1 | – | Sell |
-541,000
| Closed | -$20.9M | – | 44 |
|
|
2016
Q4 | $20.9M | Buy |
541,000
+50,418
| +10% | +$1.95M | 4.23% | 10 |
|
|
2016
Q3 | $24.8M | Sell |
490,582
-18,748
| -4% | -$949K | 4.36% | 9 |
|
|
2016
Q2 | $23.1M | Buy |
509,330
+104,010
| +26% | +$4.73M | 5.14% | 7 |
|
|
2016
Q1 | $16M | Buy |
405,320
+278,320
| +219% | +$11M | 5.59% | 6 |
|
|
2015
Q4 | $7.18M | Buy |
+127,000
| New | +$7.18M | 2.47% | 16 |
|